We propose that Luminal A breast cancers with higher levels of ER respond to single-hormone stimulation by estrogens, androgens or progesterone by activating the DREAM complex, inhibiting the expression of cell cycle genes and inducing quiescence (Figure 6a). Here, KCNIP3 is linked to breast carcinoma.